Trial intelligence / Profile preview

TOURMALINE: Patiromer with or without food for hyperkalemia

NCT02694744Phase 4Completed

Sponsor
Relypsa, Inc.
Start
Feb 2016
Primary completion
Jul 2016
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of patiromer in hyperkalemia, sponsored by Relypsa, Inc.. Started Feb 2016; status: completed.

02

Drugs

patiromer
03

Conditions

hyperkalemia

Beyond the preview

Go deeper on NCT02694744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02694744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call